SCHUETZ THOMAS J. (Chief Executive Officer) received a stock award from COMPASS THERAPEUTICS, INC.
Compensation award — not an open‑market transaction. Less informative as a directional signal.
A · 1 award
Filed: 1/5/2026ACC: 0001171843-26-000060
DirectorOfficer· Chief Executive Officer
Since Jun 2020
+2.25M
Net shares
Net buyer
$1.29M
Total acquired
0
Open market trades
0B · 0S
2
Total transactions
2.25M acquired
Non-Derivative Transactions1
Common Stock
Direct
Shares
+250K
Price / share
$5.17
Trade value
$1.29M
% of position
3.9%
1/2/2026
6.44M→6.69M
Total
Net shares
+250K
Net value
$1.29M
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 1/2/2026 | A · Award | +250K | $5.17 | $1.29M | 3.9% | 6.44M | 6.69M |
| Total | +250K | $1.29M | ||||||
Derivative Transactions1
Stock Option (Right to Buy)
Direct
Converts to
Common Stock
2M shares
Shares
+2M
Strike price
5.17
Held after
2M
Exercisable
—
1/2/2026
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy) Direct | Common Stock2M shares | 1/2/2026 | A · Award | +2M | 5.17 | — | 2M |